Latest News

Date Title Topic
15 Dec 2018 Data from the OAK Trial Show Fast Progression Is Not More Common with Atezolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
15 Dec 2018 Pembrolizumab Improves Long-term Overall Survival over Docetaxel in Advanced NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
15 Dec 2018 Neoadjuvant Ipilimumab plus Nivolumab Demonstrates Promising Overall Survival and Relapse-free Survival in Stage III Melanoma Cancer Immunology and Immunotherapy
15 Dec 2018 Proton Pump Inhibitor Therapy Negatively Impacts the Efficacy of Nivolumab Plus Ipilimumab Combination Treatment in Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
13 Dec 2018 Second-Line Nivolumab Is Not Superior to Chemotherapy in SCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
13 Dec 2018 First Line Immunotherapy Combination Fails to Improve Overall Survival in Lung Cancer [ESMO Press Release] Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
11 Dec 2018 ESMO Immuno-Oncology Congress Showcases New Technologies Set to Improve Cancer Treatment [ESMO Press Release] Cancer Immunology and Immunotherapy
11 Dec 2018 Death Rates from Cancer will Fall in Australasian Countries and Russia in 2018: Researchers Call for Urgent Measures on Tobacco control, Especially in Russia [Annals of Oncology Press Release]
10 Dec 2018 Immuno-Oncology Technology (IOTECH)
07 Dec 2018 FDA Approves Atezolizumab with Chemotherapy and Bevacizumab for First-line Treatment of Metastatic Non-squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
06 Dec 2018 Adjuvant T-DM1 in HER2-positive Early Breast Cancer With Residual Invasive Disease After Completion of Neoadjuvant Therapy Breast cancer - Anticancer agents & Biologic therapy
29 Nov 2018 ESMO Immuno-Oncology Congress: Where the Community of Stakeholders Meets [ESMO Media Alert] Cancer Immunology and Immunotherapy
22 Nov 2018 ESMO Clinical Practice Guidelines
22 Nov 2018 ESMO Immuno-Oncology 2018 Congress Coverage